Cycle Pharma

Cambridge, United Kingdom Founded: 2012 • Age: 14 yrs
Small molecule drugs are reformulated and repurposed for orphan indications.
Request Access

About Cycle Pharma

Cycle Pharma is a company based in Cambridge (United Kingdom) founded in 2012.. The company has 54 employees as of December 31, 2021. Cycle Pharma has completed 2 acquisitions, including Applied Therapeutics and Banner Life Sciences. Cycle Pharma offers products and services including Cycle Vita and VENXXIVA. Cycle Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Alnylam, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 54 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cycle Pharmaceuticals Ltd
  • Date of Incorporation 02 Feb, 2012
  • Jurisdiction CAMBRIDGE, ENGLAND
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $30.23 M (USD)
    31
    as on Dec 31, 2020
  • Net Profit
    $10.71 M (USD)
    67
    as on Dec 31, 2020
  • EBITDA
  • Latest Funding Round
    $25 M (USD), Debt – Conventional

    Sep 07, 2020

  • Investors
  • Employee Count
    54

    as on Dec 31, 2021

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cycle Pharma

Cycle Pharma offers a comprehensive portfolio of products and services, including Cycle Vita and VENXXIVA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI-powered app for managing rare diseases like PKU.

Tablets for treating cystinuria and reducing pill burden.

People of Cycle Pharma
Headcount 10-50
Employee Profiles 29
Board Members and Advisors 6
Employee Profiles
People
David R.
Director Of Sales, Hematology & Oncology
People
Damien Sango
Director, Market Access And Distribution
People
Zac Bohlen
VP, US Sales
People
Catherine Wainwright
Senior Director of New Product Introduction & Programme Management

Unlock access to complete

Board Members and Advisors
people
Tony Cates
Director
people
Bill Robinson
Deputy Chairman
people
Duncan Moore
Director
people
Ross Reason
Director

Unlock access to complete

Funding Insights of Cycle Pharma

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $25.0M
  • First Round

    (07 Sep 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2020 Amount Debt – Conventional - Cycle Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cycle Pharma

Cycle Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Deutsche Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Diversified banking and financial services are provided globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cycle Pharma

Cycle Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Applied Therapeutics and Banner Life Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Drugs for metabolic and cardiovascular diseases are developed.
2015
Fully integrated product development using its formulation technologies.
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Cycle Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cycle Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cycle Pharma

Cycle Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Alnylam, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
RNA interference-based therapeutics are developed for multiple disorders.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cycle Pharma

Frequently Asked Questions about Cycle Pharma

When was Cycle Pharma founded?

Cycle Pharma was founded in 2012 and raised its 1st funding round 8 years after it was founded.

Where is Cycle Pharma located?

Cycle Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

How many employees does Cycle Pharma have?

As of Dec 31, 2021, the latest employee count at Cycle Pharma is 54.

What is the annual revenue of Cycle Pharma?

Annual revenue of Cycle Pharma is $30.23M as on Dec 31, 2020.

What does Cycle Pharma do?

Cycle Pharma was founded in 2012 and is based in Cambridge, United Kingdom. Operations focus on biopharmaceutical development, including reformulation and repurposing of small molecule drugs for orphan diseases. FDA approval was granted in August 2017 for NITYR (nitisinone tablets), used to treat Hereditary Tyrosinemia type 1, with a formulation that avoids refrigeration and allows dissolution in water for pediatric use. Generics are also manufactured by the company.

Who are the top competitors of Cycle Pharma?

Cycle Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

What products or services does Cycle Pharma offer?

Cycle Pharma offers Cycle Vita and VENXXIVA.

How many acquisitions has Cycle Pharma made?

Cycle Pharma has made 2 acquisitions, including Applied Therapeutics, and Banner Life Sciences.

Who are Cycle Pharma's investors?

Cycle Pharma has 1 investor. Key investors include Deutsche Bank.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available